Reinhardt, Philipp
Giger, Roland
Seifert, Eberhard
Shelan, Mohamed
Riggenbach, Elena
Terribilini, Dario
Joosten, Andreas
Schanne, Daniel H.
Aebersold, Daniel M.
Manser, Peter
Dettmer, Matthias S.
Simon, Christian
Ozsahin, Esat M.
Moeckli, Raphaël
Limacher, Andreas
Caparrotti, Francesca
Nair, Deepa
Bourhis, Jean
Broglie, Martina A.
Al-Mamgani, Abrahim
Elicin, Olgun http://orcid.org/0000-0002-6996-0646
Funding for this research was provided by:
Krebsliga Schweiz (KLS-4567-08-2018)
Rising Tide Foundation for Clinical Cancer Research (CCR-19-300)
Article History
Received: 21 September 2022
Accepted: 14 October 2022
First Online: 27 October 2022
Declarations
:
: The study is listed in ExternalRef removed and in the Swiss National Clinical Trials Portal (NCT04057209) after approval by the local ethics committee (Cantonal Ethics Committee Bern/ Switzerland, KEK-BE 2019-01506). Written, informed consent to participate is and will be obtained from all participants before participating into the trial.
: Not applicable.
: The authors declare that they have no competing interests.